Eva Cernuda‐Morollón

3.6k total citations
42 papers, 2.9k citations indexed

About

Eva Cernuda‐Morollón is a scholar working on Molecular Biology, Psychiatry and Mental health and Pathology and Forensic Medicine. According to data from OpenAlex, Eva Cernuda‐Morollón has authored 42 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 17 papers in Psychiatry and Mental health and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Eva Cernuda‐Morollón's work include Migraine and Headache Studies (17 papers), Trigeminal Neuralgia and Treatments (11 papers) and Immune Cell Function and Interaction (6 papers). Eva Cernuda‐Morollón is often cited by papers focused on Migraine and Headache Studies (17 papers), Trigeminal Neuralgia and Treatments (11 papers) and Immune Cell Function and Interaction (6 papers). Eva Cernuda‐Morollón collaborates with scholars based in Spain, United Kingdom and Chile. Eva Cernuda‐Morollón's co-authors include Julio Pascual, Dolores Pérez‐Sala, César Ramón, Davinia Larrosa, Pablo Martínez‐Camblor, F. Javier Cañada, Esther Serrano‐Pertierra, Anne J. Ridley, Estela Pineda‐Molina and Déla Golshayan and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Blood.

In The Last Decade

Eva Cernuda‐Morollón

42 papers receiving 2.8k citations

Peers

Eva Cernuda‐Morollón
Anna Lisa Giuliani Italy
Ben J. Gu Australia
Gijs Kooij Netherlands
Junichi Hamada Japan
Richard E. Kast United States
Jo Van Dorpe Belgium
Xingang Li China
Nuray Erin Türkiye
Guang Chen China
Carlo Avolio Italy
Anna Lisa Giuliani Italy
Eva Cernuda‐Morollón
Citations per year, relative to Eva Cernuda‐Morollón Eva Cernuda‐Morollón (= 1×) peers Anna Lisa Giuliani

Countries citing papers authored by Eva Cernuda‐Morollón

Since Specialization
Citations

This map shows the geographic impact of Eva Cernuda‐Morollón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Cernuda‐Morollón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Cernuda‐Morollón more than expected).

Fields of papers citing papers by Eva Cernuda‐Morollón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Cernuda‐Morollón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Cernuda‐Morollón. The network helps show where Eva Cernuda‐Morollón may publish in the future.

Co-authorship network of co-authors of Eva Cernuda‐Morollón

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Cernuda‐Morollón. A scholar is included among the top collaborators of Eva Cernuda‐Morollón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Cernuda‐Morollón. Eva Cernuda‐Morollón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García‐Cabo, Carmen, Cristina Martín-Martín, Belén Prieto García, et al.. (2024). Mediterranean Diet Prior to Ischemic Stroke and Potential Circulating Mediators of Favorable Outcomes. Nutrients. 16(18). 3218–3218. 2 indexed citations
2.
Serrano‐Pertierra, Esther, Myriam Oliveira-Rodríguez, Montserrat Rivas, et al.. (2019). Characterization of Plasma-Derived Extracellular Vesicles Isolated by Different Methods: A Comparison Study. Bioengineering. 6(1). 8–8. 107 indexed citations
3.
Ruíz, Marina, Julio Pascual, Mónica Sobrado, et al.. (2019). CALCA and TRPV1 genes polymorphisms are related to a good outcome in female chronic migraine patients treated with OnabotulinumtoxinA. The Journal of Headache and Pain. 20(1). 39–39. 26 indexed citations
4.
Cernuda‐Morollón, Eva, et al.. (2017). Neuropeptides as a Marker for Chronic Headache. Current Pain and Headache Reports. 21(4). 18–18. 49 indexed citations
5.
Serrano‐Pertierra, Esther, et al.. (2015). Increased natural killer cell chemotaxis to CXCL12 in patients with multiple sclerosis. Journal of Neuroimmunology. 282. 39–44. 11 indexed citations
6.
Cernuda‐Morollón, Eva, César Ramón, Pablo Martínez‐Camblor, et al.. (2015). OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine. Pain. 156(5). 820–824. 148 indexed citations
7.
Marcos‐Ramiro, Beatriz, Esther Serrano‐Pertierra, Miguel Ángel Blanco-Gelaz, et al.. (2014). Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function. BMC Neuroscience. 15(1). 110–110. 83 indexed citations
8.
Reglero-Real, Natalia, Adrián Álvarez-Varela, Eva Cernuda‐Morollón, et al.. (2014). Apicobasal Polarity Controls Lymphocyte Adhesion to Hepatic Epithelial Cells. Cell Reports. 8(6). 1879–1893. 13 indexed citations
9.
10.
Ayala, Antonio Saiz, Davinia Larrosa, Eva Cernuda‐Morollón, et al.. (2013). Chronic migraine does not increase posterior circulation territory (PCT) infarct-like lesions. Journal of the Neurological Sciences. 336(1-2). 180–183. 10 indexed citations
11.
Serrano‐Pertierra, Esther, Eva Cernuda‐Morollón, & Carlos López‐Larrea. (2012). Wiskott‐Aldrich syndrome protein (WASp) and N‐WASp are involved in the regulation of NK‐cell migration upon NKG2D activation. European Journal of Immunology. 42(8). 2142–2151. 9 indexed citations
12.
Cernuda‐Morollón, Eva, Severine Gharbi, & Jaime Millán. (2010). Discriminating Between the Paracellular and Transcellular Routes of Diapedesis. Methods in molecular biology. 616. 69–82. 7 indexed citations
13.
Cernuda‐Morollón, Eva, et al.. (2010). Rac Activation by the T-Cell Receptor Inhibits T Cell Migration. PLoS ONE. 5(8). e12393–e12393. 51 indexed citations
14.
Datta, Arpita, Sarah J. Glennie, Diane Scott, et al.. (2006). Differential Effects of Immunosuppressive Drugs on T-Cell Motility. American Journal of Transplantation. 6(12). 2871–2883. 15 indexed citations
15.
Sánchez-Gómez, Francisco J., Eva Cernuda‐Morollón, Konstantinos Stamatakis, & Dolores Pérez‐Sala. (2004). Protein Thiol Modification by 15-deoxy-Δ12,14-Prostaglandin J2 Addition in Mesangial Cells: Role in the Inhibition of Pro-inflammatory Genes. Molecular Pharmacology. 66(5). 1349–1358. 70 indexed citations
16.
Pérez‐Sala, Dolores, Eva Cernuda‐Morollón, & F. Javier Cañada. (2003). Molecular Basis for the Direct Inhibition of AP-1 DNA Binding by 15-Deoxy-Δ12,14-prostaglandin J2. Journal of Biological Chemistry. 278(51). 51251–51260. 122 indexed citations
17.
Pérez‐Sala, Dolores, Eva Cernuda‐Morollón, Estela Pineda‐Molina, & F. Javier Cañada. (2002). Contribution of Covalent Protein Modification to the Antiinflammatory Effects of Cyclopentenone Prostaglandins. Annals of the New York Academy of Sciences. 973(1). 533–536. 26 indexed citations
18.
Cernuda‐Morollón, Eva, Fernando Rodríguez‐Pascual, Peter Klatt, Santiago Lamas, & Dolores Pérez‐Sala. (2002). PPAR Agonists Amplify iNOS Expression While Inhibiting NF-κB. Journal of the American Society of Nephrology. 13(9). 2223–2231. 60 indexed citations
19.
Stamatakis, Konstantinos, Eva Cernuda‐Morollón, Octavio Hernández‐Perera, & Dolores Pérez‐Sala. (2002). Isoprenylation of RhoB Is Necessary for Its Degradation. Journal of Biological Chemistry. 277(51). 49389–49396. 58 indexed citations
20.
Cernuda‐Morollón, Eva, Estela Pineda‐Molina, F. Javier Cañada, & Dolores Pérez‐Sala. (2001). 15-Deoxy-Δ12,14-prostaglandin J2Inhibition of NF-κB-DNA Binding through Covalent Modification of the p50 Subunit. Journal of Biological Chemistry. 276(38). 35530–35536. 263 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Lisa Giuliani Breakdown of academic impact, for papers by Ben J. Gu Breakdown of academic impact, for papers by Gijs Kooij Breakdown of academic impact, for papers by Junichi Hamada Breakdown of academic impact, for papers by Richard E. Kast Breakdown of academic impact, for papers by Jo Van Dorpe Breakdown of academic impact, for papers by Xingang Li Breakdown of academic impact, for papers by Nuray Erin Breakdown of academic impact, for papers by Guang Chen Breakdown of academic impact, for papers by Carlo Avolio
Rankless by CCL
2026